Navigation Links
Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter
Date:7/23/2009

SAN JOSE, Calif., July 23 /PRNewswire-FirstCall/ -- Oclaro, Inc. (Nasdaq: OCLR), a leading provider of optical components, modules and subsystems, today announced the financial results for its fourth fiscal quarter and fiscal year ended June 27, 2009. Oclaro, Inc. was formed April 27, 2009 from the combination of Bookham, Inc., renamed Oclaro, Inc. on that date, and Avanex Corporation.

"Being positive Adjusted EBITDA in our first quarter together is an important milestone for Oclaro. Our integration is going smoothly, our synergies are on track and we believe our customers are pleased with the deal. These results are a visual indicator of the progress taking place behind the scenes and with customers," said Alain Couder, CEO of Oclaro, Inc. "Times continue to be challenging, and we expect only modest revenue growth in the remainder of calendar 2009. Over the upcoming quarters we will continue to focus to advance the profitability of Oclaro towards our ultimate operating model targets."

Highlights: Fourth Fiscal Quarter 2009

  • GAAP revenues were $66.9 million for the quarter ended June 27, 2009 compared to $41.2 million in the quarter ended March 28, 2009. GAAP gross margin was 25% for the quarter ended June 27, 2009, compared to 21% in the quarter ended March 28, 2009.
    • GAAP revenues exclude New Focus revenues of $5.1 million and $5.8 million for the quarters ended June 27, 2009 and March 28, 2009, respectively, as New Focus results of operation are disclosed as discontinued operations as a result of the transfer of our New Focus business to Newport Corporation in exchange for their Spectra-Physics laser diode business and $3.0 million in cash in a transaction that closed July 4, 2009.

  • '/>"/>

SOURCE Oclaro, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Oclaro Launches Eye-Safe High Power Laser Diodes at LASER 2009
2. Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
4. Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
5. Digirad Corporation Reports Second Quarter 2009 Financial Results
6. Affymetrix Reports Second Quarter 2009 Results
7. Exponent Reports Second Quarter 2009 Results
8. Endologix Reports 42% Second Quarter 2009 Revenue Growth
9. Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results
10. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
11. Amylin Pharmaceuticals Reports Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)..., The copper sequestering drug tetrathiomolybdate... the treatment of Wilson disease, a disease caused...cancers. That much is known. Very little, however,...r level. , A new study led by Northwestern Unive...lue: the three-dimensional structure of TM bound t...
(Date:11/26/2009)..., No more letters from th...or,personalized text messages from Santa , ...effort to increase operational efficiencies at the...ng to help keep children all over the globe inform... ,Elves in Santa’s research department have ...
(Date:11/26/2009)..., Benton Communications a...iness growth system for retailers struggling to ma... (PRWEB) November 26, 2009 -- Flu fears is the ty...es to the emergency room, according to Dr. David B...wly released business growth system – The R...
(Date:11/25/2009)..., , KANSAS CITY, Mo., Nov. 25 /PRNewswir...rarily become the nation,s largest medical clinic ... a series of massive free clinics for uninsured pe...ial to be the biggest one yet, because it will ext...on weekdays instead of over a weekend," Sheri Wood...
(Date:11/25/2009)..., , TORONTO, Nov. 25 /PRNewswire/ - Senti...st MRI coils and advanced visualization software l...cations on its Aegis(TM) medical imaging software ...rth America (RSNA) annual meeting in Chicago, Nov....cations leverage the unique high quality images ge...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...lects Robust Growth of Client Intuitive Surgical,s...April 21 The Chamberlain Group, producers of anat...ed their new Uterine Robotic Surgery Trainer. , ,... feels like living tissue, has appropriate elastic...
...T WORTH, Texas, April 21 Wound Care Innovations, ..., Inc., (OTC Bulletin Board: WNDM), announced toda...Xenos Partners, LLC (QX Partners) to market and di...mall Business (SDVOB) that provides expertise and ...
...STON, April 21 More people are turning to a new t...ion - tattooing. A case report will be presented ...nical Endocrinologists (AACE) 18th Annual Meeting ...om/cgi-bin/prnh/20090324/DC88061LOGO-b ) , , One ...
... Ohio State University Medical Center Implants T...t Assist System Under FDA-Approved Clinical Trial ...e Heart (ASX: SHC), a global medical device compan...completed the first two implants of the Company,s ...
...m denial to missing important details: A new surve...dult children can suffer when a parent has a heari...nction with Better Hearing and Speech Month in May...rent,s relationship with their adult children. Ene...
... , AUSTIN, Texas, April 21 Bates County Memori...ted in Butler, MO and serving Bates County and sur...ions, Inc. to implement the OpusClinicalSuite(R) E...aternity care, with extensive outpatient specialty...
Other Medicine News:Health News:Chamberlain Group Announces New Uterine Robotic Surgery Training Device 2Health News:Chamberlain Group Announces New Uterine Robotic Surgery Training Device 3Health News:Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC 2Health News:Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC 3Health News:New Research Reveals Need for Doctors to Know About Medical Tattoos 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 2Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 3Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 4Health News:Children Speak Up: A Parent's Hearing Loss Hinders Relationships 5Health News:Bates County Memorial Hospital Selects Opus Healthcare Solutions, Inc. to Implement the OpusClinicalSuite(R) EMR 2Health News:Bates County Memorial Hospital Selects Opus Healthcare Solutions, Inc. to Implement the OpusClinicalSuite(R) EMR 3
(Date:11/25/2009)...Nov. 25 /PRNewswire-Asia-FirstCall/ -- China Sky O...Company") (Nasdaq: CSKI ), a,leading fully integr...ng,over-the-counter drugs in the People,s Republic...y recently passed the Chinese National Institute f...oducts ("ICPBP") examination,for two of its new pr...
(Date:11/25/2009)... Nov. 25 Swissray International, I...graphy ( ddR ) systems, announced today that its o...vestor with a long term view towards growing Swiss...ded all assets and intellectual property, as well ...ess and growth Swissray is now poised to move to t...
(Date:11/25/2009)... Reportlinker.com announces that a ...alogue: ,, Pain Management - Global Trends ...anagement---Global-Trends.html ,, Widespread a...nagement clinics, and the advent of new drugs have...ment market. Healthcare reforms and reimbursement ...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 1Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 2American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 1American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 2American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 3Heartline 28R 29 Fitness Systems Named to Inc 5000 list for Third Consecutive Year 54838 1Heartline 28R 29 Fitness Systems Named to Inc 5000 list for Third Consecutive Year 54838 2
... Sept. 24 Alimera Sciences, Inc., a privately,hel...e research,development and commercialization of pr...ted that after completing its review of safety,and... Data Safety,Monitoring Board (DSMB) has again rec...als for the use of Iluvien(TM) in the treatment of...
... survey shows high prevalence of "bothersome" vagi...non-sexually active postmenopausal, women; resul...enopause Society Meetin... of a,Phase 3 study for Ophena(TM) (ospemifene tab...l atrophy (VVA) in postmenopausal women showed tha...
Other Medicine Technology:DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 2DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4
Miami Hip Orthosis
Boston Post-Op Hip Orthosis
... significant advance in walker design in years. A ...e weight bearing surfaces of the foot rest on adap...the heel strike. The footbed in the sole conforms ... and stability. , ,No leg length discrepancy; Hee...
...rovides comfortable stability for acute ankle spra... fractures of the lower leg and ankle, and stable ...er are available to accommodate larger patients.Th...s ideal for acute ankle sprains, forefoot and midf...
Medicine Products: